LAS VEGAS, Feb. 27, 2018 -- VITALIBIS, INC. (OTC PINK:SALLD) a technology based seller of premium, full spectrum CBD products, along with personal care and nutritional products formulated with premium hemp extracts, today provided an outline regarding its mission and core product line.
Vitalibis is focused on creating, under its VITALIBIS™ trademark, an iconic lifestyle brand which promotes health and wellness within the rapidly growing medicinal cannabis industry. Vitalibis is utilizing a robust technology platform and an innovative micro-influencer sales model to market and sell its CBD, personal care and nutritional products. In addition to leveraging technology and selling high-quality products, Vitalibis will provide support to non-profits with environmental and neuro-emotional missions.
Vitalibis’ mission and core product lines include:
PREMIUM, FULL SPECTRUM CBD PRODUCTS
At Vitalibis we market and sell premium, full spectrum CBD products with less than .3% THC content. The agricultural hemp used by Vitalibis is responsibly grown within the United States under the regulations of the Colorado Department of Agriculture Industrial Hemp Program. The oils are extracted using a patented process, which retains the cannabinoids, flavonoids and terpenes for full benefit. After commercialization by a cGMP facility, the oils are thoroughly tested by trusted and fully certified third-party labs for efficacy and safety.
COLD PROCESSED SKIN and BODY CARE LINES
At Vitalibis, safety and efficacy are paramount. Vitalibis will follow a robust process to screen every ingredient to understand if it’s harmful to human health. Part of this process will use the Environmental Working Group (EWG) Skin Deep Cosmetics Database and other scientific research findings to help guide decisions on what to use in our proprietary formulations. The Vitalibis products include premium hemp oil and are made using cold-processed technology adhering to cGMP standards, to minimize heat and harmful ingredients and are subjected to strict scientific monitoring and testing by independent third-party labs for testing.
ORGANIC CERTIFIED NUTRITION
Vitalibis hemp-based nutritional products are, manufactured in cGMP, organic certified facilities and thoroughly tested by independent and trusted third-party labs.
Steven Raack, CEO of Vitalibis, commented, “A major focus of ours is to provide our customers with safe, efficacious products. We have high standards and will work hard to ensure our products do not include any harsh or harmful chemicals. At our core, we are a lifestyle brand promoting health and wellness. In that regard, we firmly believe the cannabis plant has amazing properties, and as a result, we are excited to share our Vitalibis products with you, your friends and your families.”
About Vitalibis Inc.
Vitalibis endeavours to be an iconic lifestyle brand, which promotes health and wellness within the rapidly growing medicinal cannabis industry. Vitalibis seeks to utilize a robust technology platform and innovative micro-influencer sales model to market and sell premium, full spectrum CBD products, along with personal care and nutritional products formulated with premium hemp extracts. In addition to leveraging technology and selling high-quality products, Vitalibis will focus on supporting non-profits with environmental and neuro-emotional missions.
For additional information, www.vitalibis.com
Contact:
Vitalibis Inc.
702-944-9620
[email protected]
FORWARD LOOKING STATEMENT
This news release includes forward-looking statements that reflect Vitalibis Inc. current expectations about its future results, performance, prospects and opportunities Vitalibis, Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities for the remainder of 2018 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.


Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



